Trials / Completed
CompletedNCT00708370
A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.
An Outcome Research on the Impact of a Disease Management Program (COACH) on the Attainment of Better Cardiovascular Risk Control in Dyslipidemic Patients at Primary Care Centers (DISSEMINATE).
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 297 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a local PCO sponsored, interventional, non-drug study to evaluate the efficacy of a health tele-counselling program in reducing cardiovascular risk in dyslipidemic patients.
Detailed description
Educational / Counseling
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | COACH | COACH Nurse will provide health tele-counselling to patients randomized to COACH arm fortnightly for 24 weeks. |
| OTHER | No intervention for placebo | There will be no COACH health tele-counselling to patients randomized to Standard Care arm. |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2010-05-01
- Completion
- 2010-06-01
- First posted
- 2008-07-02
- Last updated
- 2021-02-18
Locations
22 sites across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT00708370. Inclusion in this directory is not an endorsement.